Table Of Content. D Final Report 'Primary Care Anti-infective agent prescribing for Common
|
|
- Aleesha Sutton
- 5 years ago
- Views:
Transcription
1 Table Of Content Antibiotic Resistance and Prescribing in European Children... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Associação de Saúde Infantil de Coimbra... 5 University of Tartu... 5 University Medical Centre Ljubljana... 5 Vilnius University Children Hospital... 5 The European Society for Paediatric Infectious Diseases (until 01/07/2013)... 5 Fondazione PENTA for the treatment and care of children with HIV and related diseases - ONLUS... 5 University Medical Center Freiburg... 5 Erasmus Universitair Medisch Centrum Rotterdam... 5 Universiteit Antwerpen... 5 Servicio Madrileno de Salud - (SERMAS)... 5 Università Degli Studi Di Milano... 5 Consorzio per Valutazioni Biologiche e Farmacologiche... 5 Società Servizi Telematici s.r.l National and Kapodistrian University of Athens... 5 Outputs... 8 D01 - Formalised Community Project Protocol 'Protocol for Drug Utilization Study' (EN)... 8 D Interim Report 'Primary Care Anti-infective agent prescribing for Common Childhood Infections' (EN)... 8 D Final Report 'Primary Care Anti-infective agent prescribing for Common Childhood Infections' (EN)... 8 D Final Report 'Primary Care Anti-infective agent prescribing for Common Childhood Infections' (EN)... 8 D 'Introductory Training Module in Prudent Antibiotic Prescribing' (EN)... 8 D05 - 'Interim Report on the Paediatric & Neonatal PPS on Antimicrobial Prescribing in European Hospitals' (EN)... 8 D Final Report on the Paediatric & Neonatal PPS on Antimicrobial Prescribing in European Hospitals (EN)... 8 D 'EARSS based Paediatric antimicrobial resistance tool' (EN)... 8 D Report 'Variation on antimicrobial resistance for key pathogens causing serious infections in children (EN)... 8 D Report 'Variation of antibiotic prescribing guidelines' (EN)... 8 D Intermediate Technical and Financial reports & Final Technical and Financial reports (EN)... 8 D Intermediate Technical and Financial reports & Final Technical and Financial reports (EN)... 8 D Intermediate Technical and Financial reports & Final Technical and Financial reports (EN)... 8 Final Technical Report... 8 Flyers (EN)... 8 Internal Assessment (EN)... 8 Leaflets (EN)... 8 Page 1/11
2 Antibiotic Resistance and Prescribing in European Children JA GPSD [705038] START DATE: 01/09/2010 END DATE: 01/01/2014 DURATION: 40 month(s) CURRENT STATUS: Finalised PROGRAMME TITLE: Second Programme of Community action in the Field of Health PROGRAMME PRIORITY: - CALL: Improve Citizen''S Health Security (Hs-2009) TOPIC: IMPROVE CITIZEN'S HEALTH SECURITY (HS-2009) EC CONTRIBUTION: EUR KEYWORDS: Antimicrobial Resistance, Bacteria, Children, Emergent pathogens, Treatment PORTFOLIO: Antimicrobial resistance Page 2/11
3 SUMMARY General objectives The general objective of the project is to improve the quality of antibiotic prescribing for children in Europe. The specific objectives include determining the variation in antibiotic prescribing for common childhood infections in the community and hospitals across Europe, compared to local guidelines. The project will also systematically compare rates of antimicrobial resistance. There has been a limited focus on education on antimicrobial resistance on pediatricians. The project will aim to kick start a new network of PID specialists working in close collaboration and building on the existing EU funded surveillance projects. ARPEC will use key opinion leaders within ESPID to try to develop the evidence base for the variation in antibiotic resistance and prescribing. This will then directly translate into long term educational programmes focussing on trainee pediatricians and formalise educational training packages in prudent antimicrobial prescribing. Strategic relevance and contribution to the public health programme The World Heath Assembly of 1998 urged member states to develop sustainable systems to monitor volumes and patterns of antimicrobials, detect resistant pathogens and improve educational programmes encouraging prudent antimicrobial use. The project will build on the ESAC and EARSS programmes, working with the ECDC to develop a sustainable surveillance and educational programme for antimicrobial prescribing and antibiotic resistance in children. The core focus of the project is the optimisation of antimicrobial prescribing for children in Europe and this remains a key part of the ECDC work plan. The aim of this first phase of the project is to make the long term routine data collection self-sustainable from participating countries, with the future focus being on the optimal educational methodologies to reduce inappropriate prescribing. Methods and means The project will determine the variation in drug, dose and indications for community and hospital antibiotic prescribing for common childhood infections between EU countries. For community pediatric prescribing variation in both overall and antibiotic class-specific rates will be determined between countries. The programme will produce a novel pediatric defined daily dose (DDD) methodology and conduct an EUwide point prevalence survey to compare antibiotic use in children in hospital. Using established EARSS methodology, information on bacteremia rates and antimicrobial susceptibility patterns for selected common pathogens in Europe will be collected for major children`s hospitals in Partner countries. ARPEC will feed back the project results through regional meetings and use an established web-based methodology for a new ESPID educational training programme Page 3/11
4 on prudent prescribing. Expected outcomes period The PPS study would provide for the first time detailed indication and age specific hospital prescribing data on antibiotics for medical and surgical treatment and prophylaxis. Key Outcome: Direct comparison data on hospital antibiotic prescribing practice that can be fed directly back to prescribers. The Antimicrobial resistance work package will identify resistance rates for specific pathogens to selected antibiotics in children. 2 key outcomes will be: 1)identify trends in penicillin-resistant pneumococci between countries following introduction of conjugate pneumococcal vaccine across Europe as the date of introduction, the schedule and uptake of this vaccine vary significantly. 2) determination of the spread of multi-resistant gram negative pathogens in community and hospitals in Europe. Community antibiotic prescribing for common childhood infections WP. Key outcome: differences in actual prescribed antibiotics for specific countries compared to their guidelines. This data will provide the basis for future intervention programmes to reduce inappropriate antibiotic prescribing. Page 4/11
5 COORDINATOR, LEADER CONTACT AND PARTNERS COORDINATOR St George's University of London (St George's University of London) Cranmer Terrace SW17 0RE London United Kingdom Project leader contact Name: Sharland Mike Phone: PARTNERS Associação de Saúde Infantil de Coimbra Street: Hospital Pediátrico de Coimbra, Av. Bissaya Barreto City: Coimbra Country: Portugal University of Tartu Street: Ülikooli 18 City: Tartu Country: Estonia University Medical Centre Ljubljana Street: Zaloška cesta 002 City: 1000 Ljubljana Country: Slovenia Page 5/11
6 Vilnius University Children Hospital Street: Santariskiu 4 City: LT Vilnius Country: Lithuania The European Society for Paediatric Infectious Diseases (until 01/07/2013) Street: Peters, Schoenberger & Partner GbRzHd Frau Ina BestlerSchackstr. 2 City: D Muenchen Country: Germany Fondazione PENTA for the treatment and care of children with HIV and related diseases - ONLUS Street: Via Giustiniani 3 City: Padova Country: Italy University Medical Center Freiburg Street: Hugstetter Str. 55 City: Freiburg Country: Germany Erasmus Universitair Medisch Centrum Rotterdam Street: 's Gravendijkwal City: 3015CE Rotterdam Country: Netherlands Universiteit Antwerpen Street: Prinsstraat 13 City: 2000 Antwerpen Country: Belgium Page 6/11
7 Servicio Madrileno de Salud - (SERMAS) Street: Plaza Carlos Tris Bertran 7 City: Madrid Country: Spain Università Degli Studi Di Milano Street: via Festa del Perdono 7 City: Milano Country: Italy Consorzio per Valutazioni Biologiche e Farmacologiche Street: Via Palestro 26 City: Pavia Country: Italy Società Servizi Telematici s.r.l. Street: Via G. Medici 9/A City: Padova Country: Italy National and Kapodistrian University of Athens Street: Christou Lada 6 City: Athens Country: Greece Page 7/11
8 OUTPUTS D01 - Formalised Community Project Protocol 'Protocol for Drug Utilization Study' (EN) ocol_en_ps.pdf D Interim Report 'Primary Care Antiinfective agent prescribing for Common Childhood Infections' (EN) r_en_ps1.pdf D Final Report 'Primary Care Antiinfective agent prescribing for Common Childhood Infections' (EN) eb_based_survey_en_is.pdf D Final Report 'Primary Care Antiinfective agent prescribing for Common Childhood Infections' (EN) Page 8/11
9 rotocol_en_is.pdf D 'Introductory Training Module in Prudent Antibiotic Prescribing' (EN) r_en_ps.pdf D05 - 'Interim Report on the Paediatric & Neonatal PPS on Antimicrobial Prescribing in European Hospitals' (EN) y_protocol_for_pilot_study_en_is.pdf D Final Report on the Paediatric & Neonatal PPS on Antimicrobial Prescribing in European Hospitals (EN) r_en_ps.pdf D 'EARSS based Paediatric antimicrobial resistance tool' (EN) r_en_is.pdf Page 9/11
10 D Report 'Variation on antimicrobial resistance for key pathogens causing serious infections in children (EN) r_en_ps.pdf D Report 'Variation of antibiotic prescribing guidelines' (EN) r_en_ps.pdf D Intermediate Technical and Financial reports & Final Technical and Financial reports (EN) th-05_en_is.pdf D Intermediate Technical and Financial reports & Final Technical and Financial reports (EN) th-06_en_is.pdf Page 10/11
11 Powered by TCPDF ( D Intermediate Technical and Financial reports & Final Technical and Financial reports (EN) r_en_is.pdf Final Technical Report r_en_is1.pdf Flyers (EN) y-01_en_ps.pdf Internal Assessment (EN) ssment_note_en_is.pdf Leaflets (EN) -01_en_ps.pdf Page 11/11
Table Of Content. Outputs... 8
Table Of Content Establishment of Quality Assurances for Detection of Highly Pathogenic Bacteria of Potential Bioterrorism Risk... 2 Summary... 3 Coordinator, Leader contact and partners... 4 Swedish Institute
More informationTable Of Content. Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8
Table Of Content Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8 Conference... 8 Coordinator, Leader contact and partners... 9 Outputs... 10 Final report...
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union November 2012 Highlights on antibiotic consumption Antibiotic use is one of the main factors responsible for the development and
More informationWhat is the problem? Latest data on antibiotic resistance
European Antibiotic Awareness Day 2009 What is the problem? Latest data on antibiotic resistance Zsuzsanna Jakab, ECDC Director Launch Seminar for EAAD Stockholm, 18 November 2009 Fluoroquinolone-resistant
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22 December 2005 COM (2005) 0684 REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION
More informationPrevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices
Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite
More informationEuropean Medicines Agency role and experience on antimicrobial resistance
European Medicines Agency role and experience on antimicrobial resistance Regional Training Workshop on Antimicrobial Resistance (AMR) Responding to the global challenge of AMR threats: toward a one health
More informationProf. Otto Cars. We are overconsuming a global resource. It is a collective responsibility by governments, supranational organisatons
What are the consequences of rising antibiotic resistance for Sweden? Prof. Otto Cars Chairman The Swedish Strategic programme against antibiotic resistance (Strama) We are overconsuming a global resource
More informationConsumption of antibiotics in hospitals. Antimicrobial stewardship.
Consumption of antibiotics in hospitals. Antimicrobial stewardship. Inge C. Gyssens MD PhD Radboud university medical center, Nijmegen, The Netherlands Hasselt University, Belgium 1. Antibiotic use in
More informationWHO global and regional activities on AMR and collaboration with partner organisations
WHO global and regional activities on AMR and collaboration with partner organisations Dr Danilo Lo Fo Wong Programme Manager for Control of Antimicrobial Resistance Building the AMR momentum 2011 WHO/Europe
More informationAntimicrobial Resistance, yes we care! The European Joint Action
Antimicrobial Resistance, yes we care! The European Joint Action Context of the Joint Action General objectives Inclusive governance Conclusion Context of the Joint Action 1. Context of this Joint Action
More informationEuropean Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe
European Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe Dominique L. Monnet, Head of Disease Programme, Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Joint
More informationThe European AMR Challenge - strategic views from the human perspective -
The European AMR Challenge - strategic views from the human perspective - World Health Organization Regional Office for Europe Dr Danilo Lo Fo Wong Senior Adviser on Antimicrobial Resistance Division of
More informationThe South African AMR strategy. 3 rd Annual Regulatory Workshop Gavin Steel Sector wide Procurement National Department of Health; South Africa
The South African AMR strategy 3 rd Annual Regulatory Workshop Gavin Steel Sector wide Procurement National Department of Health; South Africa Background to AMR 2 What is Antimicrobial stewardship and
More informationAntimicrobial resistance (EARS-Net)
SURVEILLANCE REPORT Annual Epidemiological Report for 2014 Antimicrobial resistance (EARS-Net) Key facts Over the last four years (2011 to 2014), the percentages of Klebsiella pneumoniae resistant to fluoroquinolones,
More informationGlobal action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR) Challenges on the global and regional levels Zsuzsanna Jakab WHO Regional Director for Europe 13 November support the WHO 2014, global action
More informationAntimicrobial use in humans
Antimicrobial use in humans Ann Versporten Prof. Herman Goossens OIE Global Conference on the Responsible and Prudent Use of Antimicrobial Agents for Animals - 13 March 2013 - Ann.versporten@ua.ac.be Herman.goossens@uza.be
More informationInitiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector
Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector Niels Frimodt-Møller Professor, MD DMSc Dept. of Clinical Microbiology Hvidovre Hospital, Copenhagen,
More informationDraft ESVAC Vision and Strategy
1 2 3 7 April 2016 EMA/326299/2015 Veterinary Medicines Division 4 5 6 Draft Agreed by the ESVAC network 29 March 2016 Adopted by ESVAC 31 March 2016 Start of public consultation 7 April 2016 End of consultation
More informationESAC s Surveillance by Point Prevalence Measurements. by author
ESAC s Surveillance by Point Prevalence Measurements Herman Goossens, MD, PhD ESAC Co-ordinator VAXINFECTIO, Laboratory of Medical Microbiology University of Antwerp, Belgium Outline Background Point Prevalence
More informationGlobal Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat
Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat EMA Working Parties with Patients and Consumers Organisations (PCWP) and Healthcare Professionals
More informationQuelle politique antibiotique pour l Europe? Dominique L. Monnet
Quelle politique antibiotique pour l Europe? Dominique L. Monnet National Center for Antimicrobials & Infection Control Statens Serum Institut, Copenhagen, Denmark Opinion of the Section for Protection
More informationANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU
ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU Health and Food Safety John Paget (NIVEL) Dominique Lescure (NIVEL) Ann Versporten (University of Antwerp)
More informationW O s trategi g c i actio i n o n pl p a l n n on o ant n ib i i b o i t o ic i resis i tanc n e in i n Eu E r u op o e p
WHO strategic action plan on antibiotic resista ance in Europe Strengthening g surveillance Dr Danilo Lo Fo Wong Senior Adv viser AMR Backg ground AMR costs money, livelihoods and lives, and undermines
More informationStratégie et action européennes
Résistance aux antibiotiques : une impasse thérapeutique? Implications nationales et internationales Stratégie et action européennes Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial
More informationCommittee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018
7 December 2017 Committee for Medicinal Products for Veterinary Use (CVMP) Committee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018 Chairpersons Chair: D. Murphy Status Adopted in December
More informationSummary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
More informationECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013
ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013 What is the European Union? 27 Member States 24 official languages
More informationHealth Service Executive Parkgate St. Business Centre, Dublin 8 Tel:
Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel: 01 635 2500 www.hse.ie Health Service Executive Oak House, Millennium Park, Naas, Co. Kildare Tel: 045 880 400 www.hse.ie The prevention
More informationOIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2017 This report has been submitted : 2018-01-24 10:31:11 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Classical
More informationAntibiotic resistance: the rise of the superbugs
Antibiotic resistance: the rise of the superbugs Allen Cheng Associate Professor of Infectious Diseases Epidemiology, Alfred Health; Monash University About me Specialist in infectious diseases Head, Infection
More informationAntimicrobial Stewardship Northern Ireland
Antimicrobial Stewardship Northern Ireland Dr Lorraine Doherty Assistant Director of Public Health (Health Protection) Public Health Agency 15 November 2011 Co Authors Dr Muhammad Sartaj. SpR Public Health
More informationStop overuse of antibiotics in humans rational use
Stop overuse of antibiotics in humans rational use Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections (ARHAI) European Centre
More information6-7 November Ministry of Health, Youth, Sport and Voluntary Sector. Pierre Laroque Amphitheater
EUROPEAN WORKSHOP PUBLIC AWARENESS CAMPAIGNS ON THE PRUDENT USE OF ANTIBIOTICS 6-7 November 2008 Ministry of Health, Youth, Sport and Voluntary Sector Pierre Laroque Amphitheater 14, avenue Duquesne, 75350
More informationOIE Regional Commission for Europe Regional Work Plan Framework Version adopted during the 85 th OIE General Session (Paris, May 2017)
OIE Regional Commission for Europe Regional Work Plan Framework 2017-2020 Version adopted during the 85 th OIE General Session (Paris, May 2017) Chapter 1 - Regional Directions 1.1. Introduction The slogan
More informationSECOND REPORT FROM THE COMMISSION TO THE COUNCIL
SECOND REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION (2002/77/EC) ON THE PRUDENT USE OF ANTIMICROBIAL AGENTS IN HUMAN
More informationHSE - Health Protection Surveillance Centre Surveillance of Antimicrobial Consumption in Ireland
Surveillance of Antimicrobial Consumption in Ireland Ajay Oza A European Study on the Relationship between Antimicrobial Use and Antimicrobial Resistance (1998-1999) Bronzwaer et al 2002 Emerging Infectious
More informationAntimicrobial resistance and antimicrobial consumption in Europe
Antimicrobial resistance and antimicrobial consumption in Europe Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Programme Vilnius, 28 November
More informationREPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT
1 REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT The Department of Health organised a summit on Antimicrobial Resistance (AMR) the purpose of which was to bring together all stakeholders involved
More informationNational Action Plan development support tools
National Action Plan development support tools Sample Checklist This checklist was developed to be used by multidisciplinary teams in countries to assist with the development of their national action plan
More informationAMR epidemiological situation: ECDC update
One Health Network on Antimicrobial Resistance (AMR) AMR epidemiological situation: ECDC update Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI)
More informationOECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division
OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH Michele Cecchini OECD Health Division Antimicrobial Resistance is a Global Threat Modern medicine and surgery
More informationCouncil Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting
COUNCIL OF THE EUROPEAN UNION Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting Luxembourg, 10 June 2008 The Council adopted
More informationEuropean Antibiotic Awareness Day
Initiating a pan-european health campaign - experiences from setting up the European Antibiotic Awareness Day Dr Ülla-Karin Nurm Head of Public Health Development Section, Public Health Capacity and Communication
More informationStratégies et actions au niveau européen et international: populations humaines
Stratégies et actions au niveau européen et international: populations humaines Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
More informationNAP on AMR: Singapore
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14
More informationPneumococcus: Antibiotic Resistance in the Region
Pneumococcus: Antibiotic Resistance in the Region Çiğdem Bal Kayacan Istanbul University Istanbul Faculty of Medicine Department of Microbiology & Clinical Microbiology Drug Resistance in S.pneumoniae
More informationUPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM
UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health
More informationThe challenge of growing resistance
EXECUTIVE SUMMARY Around 2.4 million people could die in Europe, North America and Australia between 2015-2050 due to superbug infections unless more is done to stem antibiotic resistance. However, three
More informationDevelopment and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics
Priority Topic B Diagnostics Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics The overarching goal of this priority topic is to stimulate the design,
More informationAntimicrobial consumption
Antimicrobial consumption Annual Epidemiological Report for 2017 Key facts Twenty-seven countries, comprising 25 EU Member States and two EEA countries (Iceland and Norway) reported data on antimicrobial
More informationExecutive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts
Executive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts Investigational Team: Diane Brideau-Laughlin BSc(Pharm),
More informationEU Action Plan to combat the rising threats from Antimicrobial Resistance: State of play
EU Action Plan to combat the rising threats from Antimicrobial Resistance: State of play Rosa M. Peran i Sala Policy Officer AMR Coordination EC Action Plan against AMR Animal Health Advisory Committee
More informationEFSA s activities on Antimicrobial resistance in the food chain. Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA
EFSA s activities on Antimicrobial resistance in the food chain Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA EFSA IS The reference body for risk assessment of food and feed in the European Union. Its
More informationConsumo y venta de antibióticos para uso en animales en Europa
Consumo y venta de antibióticos para uso en animales en Europa Jornada sobre Transmisión de Resistencia entre Humanos y Animales Plan Nacional frente a la Resistencia a los Antibióticos (PRAN) Fundación
More informationPromoting Appropriate Antimicrobial Prescribing in Secondary Care
Promoting Appropriate Antimicrobial Prescribing in Secondary Care Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2015 Introduction Background ESPAUR
More informationAntimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The
Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr Nils Anders Tegnell, Director, The Public Health Agency of Sweden The Global Challenge Antibiotics
More informationAustralia s response to the threat of antimicrobial resistance
Australia s response to the threat of antimicrobial resistance Professor Warwick Anderson AM Chief Executive Officer National Health and Medical Research Council Australia s health system Antimicrobial
More informationHealth and Food Safety. EU Guidelines for the prudent use of antimicrobials in human health
Health and Food Safety EU Guidelines for the prudent use of antimicrobials in human health CONTENTS 1 2 3 4 INTRODUCTION...5 DEFINITIONS...6 SCOPE AND PURPOSE...8 GUIDELINES...9 4.1. 4.2. 4.3. 4.4. 4.5.
More informationOptimizing use of quality antimicrobial medicines in humans
Optimizing use of quality antimicrobial medicines in humans GILLES FORTE POLICY, ACCESS AND USE ESSENTIAL MEDICINES AND HEALTH PRODUCTS 1 TITLE from VIEW and SLIDE MASTER 21 October 2016 Objectives Objective
More informationManaging AMR at the Human-Animal Interface. OIE Contributions to the AMR Global Action Plan
Managing AMR at the Human-Animal Interface OIE Contributions to the AMR Global Action Plan 6th Asia-Pacific Workshop on Multi-Sectoral Collaboration for the Prevention and Control of Zoonoses Dr Susan
More informationBelgian National Antibiotic Awareness Campaigns
Belgian National Antibiotic Awareness Campaigns Herman Goossens, Stijn De Corte, Samuel Coenen University of Antwerp and BAPCOC Joris Mateusen, Sarah Tulkens Absoluut Belgium Belgian National Antibiotic
More informationPreventing and Responding to Antibiotic Resistant Infections in New Hampshire
Preventing and Responding to Antibiotic Resistant Infections in New Hampshire Benjamin P. Chan, MD, MPH NH Dept. of Health & Human Services Division of Public Health Services May 23, 2017 To bring a greater
More informationECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials
ECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials P.-A. Belœil (EFSA) and D. Monnet (ECDC) One Health Network on Antimicrobial Resistance
More informationOptimizing Antimicrobial Stewardship Activities Based on Institutional Resources
Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov
More informationQuality indicators and outcomes in the devolved nations Scotland
Quality indicators and outcomes in the devolved nations Scotland Dr Jacqueline Sneddon, MRPharmS Project Lead, Scottish Antimicrobial Prescribing Group Federation of Infection Societies Conference Birmingham,
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Preventing the Spread of Antibiotic Resistance and Improving Patient Care (Adapted from the Centers for Disease Control and Prevention) What is Stewardship? Antimicrobial stewardship
More informationOIE Platform on Animal Welfare for Europe
OIE Platform on Animal Welfare for Europe 26 th Conference of the OIE Regional Commission for Europe Bern, Switzerland, 22-26 September 2014 Dr. Stanislav RALCHEV OIE SRR Brussels Measure the progress
More informationAntimicrobial Stewardship in Scotland
Antimicrobial Stewardship in Scotland UKCPA/FIS Scientific Meeting 18 th November 2010 Triumphs and Unintended Consequences Dr Jacqueline Sneddon Project Lead for Scottish Antimicrobial Prescribing Group
More informationA Point Prevalence Survey of Antibiotic Prescriptions and Infection in Sanandaj Hospitals, Prospects for Antibiotic Stewardship
A Point Prevalence Survey of Antibiotic Prescriptions and Infection in Sanandaj Hospitals, Prospects for Antibiotic Stewardship Jafar Soltani* Ann Versporten**, Behzad Mohsenpour*, Herman Goossen**, Soheila
More informationThe threat of multidrug-resistant microorganisms and how to deal with it in Europe
The threat of multidrug-resistant microorganisms and how to deal with it in Europe Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
More information«Antibiotic Stewardship» programmes & antibiotic resistance
«Antibiotic Stewardship» programmes & antibiotic resistance Winfried V. Kern Abteilung Infektiologie Universitätsklinikum Freiburg www.if-freiburg.de Agenda Definition Healthcare quality & patient safety
More informationDr Marc Sprenger Director Antimicrobial Resistance Secretariat Global action plan on antimicrobial resistance
Global Action Plan on Antimicrobial Resistance Dr Marc Sprenger Director Antimicrobial Resistance Secretariat When are we entering the post-antibiotic era? For some diseases we have already entered! Fatal
More informationAntibiotics and resistance in the WHO Regional Office for Europe. Dr Nienke van de Sande On behalf of the AMR Working Group
Antibiotics and resistance in the WHO Regional Office for Europe Dr Nienke van de Sande On behalf of the AMR Working Group Strengthening the fight against antimicrobial Antimicrobial APRES resistance Symposium
More informationOIE strategy on AMR and the Prudent Use of Antimicrobials
Dr. Jocelyn Mérot OIE Sub-Regional Representation for North Africa OIE strategy on AMR and the Prudent Use of Antimicrobials 14th JPC REMESA 19-20 July 2017 Naples (Italy) The OIE Strategy on AMR and the
More informationAMR situation in Europe: Strategy and vision
AMR situation in Europe: Strategy and vision Koen Van Dyck Head of Unit Bilateral International Relations Head Taskforce on AMR DG Health & Food Safety European Commission According to data from 2011,
More informationHot Topics in Antimicrobial Stewardship. Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital
Hot Topics in Antimicrobial Stewardship Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital Antimicrobial Stewardship Goals Primary Goal Optimize clinical outcomes
More informationAn agency of the European Union
An agency of the European Union Human medicines in 23 Research and development 473 overall number of scientific advice and protocol assistance requests received in 23
More informationby author ESCMID Online Lecture Library EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010
EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010 Gunnar Kahlmeter Chairman of EUCAST Terms and acronyms AST Antimicrobial Susceptibility Testing MIC Minimum Inhibitory
More informationEFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication.
EFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication. Dr. Ernesto Liebana BIOHAZ Team Leader European Food Safety Authority (EFSA) EFSA
More informationGHSA Prevent-1 (AMR) road map: Progress and implementation plan Dr. Anders Tegnell, Ministry of Health and Social Affairs, Sweden
GHSA Prevent-1 (AMR) road map: Progress and implementation plan Dr Anders Tegnell, Ministry of Health and Social Affairs, Sweden One Health One World Increasing antibiotic resistance Antibiotic use and
More informationEnglish Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR)
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Berit Muller-Pebody HCAI & AMR Department, Centre for Infectious Disease Surveillance and Control Chief Medical Officer
More informationThe evolutionary epidemiology of antibiotic resistance evolution
The evolutionary epidemiology of antibiotic resistance evolution François Blanquart, CNRS Stochastic Models for the Inference of Life Evolution CIRB Collège de France Quantitative Evolutionary Microbiology
More informationThird Global Patient Safety Challenge. Tackling Antimicrobial Resistance
Geneva 12 th -13 th March 2009 Day 1, 12 th March Third Global Patient Safety Challenge Tackling Antimicrobial Resistance Edward Kelly, Coordinator, WHO Patient Safety Programme welcomed all participants
More informationAntimicrobial consumption
SURVEILLANCE REPORT Annual Epidemiological Report for 2016 Antimicrobial consumption Key facts Twenty-nine countries, including 27 EU Member States and two EEA countries (Iceland and Norway) reported data
More informationSurveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe
Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe Carl Suetens, ECDC Presented by Håkan Hanberger ecdc.europa.eu Message/Questions from C Suetens to Workshop 7, MIE2009
More informationCombating Antibiotic Resistance: New Drugs 4 Bad Bugs (ND4BB) Subtopic 1C. Seamus O Brien and Hasan Jafri Astra Zeneca and MedImmune
Combating Antibiotic Resistance: New Drugs 4 Bad Bugs (ND4BB) Subtopic 1C Seamus O Brien and Hasan Jafri Astra Zeneca and MedImmune Need for public-private collaboration Challenges of AB R&D: 1. Unique
More informationUsing Data to Track Antibiotic Use and Outcomes
Using Data to Track Antibiotic Use and Outcomes Michelle Nemec, PharmD Thrifty White Drug Pharmacy Objectives Describe the Antibiotic Stewardship Core Element of tracking and the specific interventions
More informationMonitoring gonococcal antimicrobial susceptibility
Monitoring gonococcal antimicrobial susceptibility The rapidly changing antimicrobial susceptibility of Neisseria gonorrhoeae has created an important public health problem. Because of widespread resistance
More informationEvaluation of EU strategy to combat AMR
Evaluation of EU strategy to combat AMR Advisory Group of the Food Chain 30 April 2015 Martial Plantady Legislative officer DDG2.G4: Food, Alert Systems & Training DG Health and Food Safety Antimicrobial
More informationHow is Ireland performing on antibiotic prescribing?
European Antibiotic Awareness Campaign 2016 November Webinar Series on Antibiotic Prescribing How is Ireland performing on antibiotic prescribing? Dr Rob Cunney National Clinical Lead HCAI AMR Clinical
More informationEU strategy to fight against Antimicrobial Resistance
EU strategy to fight against Antimicrobial Resistance OECD workshop on the Economics of Antimicrobial Use in the Livestock Sector and Development of Antimicrobial Resistance Paris, 12 October 2015 Martial
More informationThe Commission activities on AMR (focus on zoonotic issues)
The Commission activities on AMR (focus on zoonotic issues) R.M. Peran i Sala European Commission, DG SANCO London, 15.09.2011 1. DG SANCO and AMR High priority status given on AMR in DG SANCO EU Commission
More informationCouncil of the European Union Brussels, 13 June 2016 (OR. en)
Council of the European Union Brussels, 13 June 2016 (OR. en) 9952/16 SAN 241 AGRI 312 VETER 58 NOTE From: To: General Secretariat of the Council Council No. prev. doc.: 9485/16 SAN 220 AGRI 296 VETER
More informationMRSA in the United Kingdom status quo and future developments
MRSA in the United Kingdom status quo and future developments Dietrich Mack Chair of Medical Microbiology and Infectious Diseases The School of Medicine - University of Wales Swansea P R I F Y S G O L
More informationAnnual report of the Scientific Network on BSE-TSE 2015
TECHNICAL REPORT APPROVED: 10 December 2015 PUBLISHED: 11 December 2015 Annual report of the Scientific Network on BSE-TSE 2015 Abstract European Food Safety Authority The EFSA Scientific Network on bovine
More informationPromoting One Health : the international perspective OIE
Promoting One Health : the international perspective OIE Integrating Animal Health & Public Health: Antimicrobial Resistance SADC SPS Training Workshop (Animal Health) 29-31 January 2014 Gaborone, Botwana
More informationAntibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines
Antibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines Report and Qualitative Risk Assessment by the Committee for Veterinary Medicinal Products Annex III Surveillance
More informationAntibiotic Stewardship Beyond Hospital Walls
Antibiotic Stewardship Beyond Hospital Walls Katie Burenheide Foster, PharmD, MS, BCPS, FCCM Pharmacy Clinical Manager & PGY1 Pharmacy Residency Director OBJECTIVES 1. Review what Antibiotic Stewardship
More information